This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaillant, F. Articles by Visvader, J. E. Search for Related Content PubMed Articles by Vaillant, F. Articles by Visvader, J. E.

The Mammary Progenitor Marker CD61/β3 Integrin Identifies Cancer Stem Cells in Mouse Models of Mammary Tumorigenesis

¹ VBCRC Laboratory, The Walter and Eliza Hall Institute of Medical Research; ² Department of Medical Oncology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia

Requests for reprints: Jane E. Visvader, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia. Phone: 61-3-9345-2494; Fax: 61-3-9347-0852; E-mail: visvader{at}wehi.edu.au.

Key Words: cancer stem cell • CD61 • mammary gland

The cells of origin and mechanisms that underpin tumor heterogeneity in breast cancer are poorly understood. Here, we have examined three mouse models of mammary tumorigenesis (MMTV-wnt-1, MMTV-neu, and p53^+/–) for changes in their epithelial cell hierarchy during the preneoplastic and neoplastic stages of tumor progression. In preneoplastic tissue, only MMTV-wnt-1 mice showed a perturbation in their epithelial subpopulations. In addition to an expanded mammary stem cell pool, repopulating cells capable of yielding extensive mammary outgrowths in vivo were revealed in the committed luminal progenitor population. These findings indicate that wnt-1 activation induces the appearance of aberrant progenitor cells, and suggest that both mammary stem and progenitor cells can serve as the cellular targets of wnt-1–induced tumorigenesis. In tumors arising in MMTV-wnt-1 tumors, the luminal epithelial progenitor marker CD61/β3 integrin identified a cancer stem cell (CSC) population that was highly enriched for tumorigenic capability relative to the CD61^– subset. CD61 expression also defined a CSC subset in 50% of p53^+/––derived tumors. No CSCs, however, could be identified in the more homogeneous MMTV-neu/erbB2 model, suggesting an alternative model of tumorigenesis. Overall, our findings show the utility of the progenitor marker CD61 in the identification of CSCs that sustain specific mammary tumors. [Cancer Res 2008;68(19):7711–7]

This article has been cited by other articles:

				C. E. Glover, K. E. Gurley, K.-H. Kim, B. Storer, M. L. Fero, and C. J. Kemp Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancer Carcinogenesis, June 1, 2009; 30(6): 1058 - 1063. [Abstract] [Full Text] [PDF]

				S. M. Pontier and W. J. Muller Integrins in mammary-stem-cell biology and breast-cancer progression - a role in cancer stem cells? J. Cell Sci., January 15, 2009; 122(2): 207 - 214. [Abstract] [Full Text] [PDF]

				M.-L. Asselin-Labat, F. Vaillant, M. Shackleton, T. Bouras, G.J. Lindeman, and J.E. Visvader Delineating the Epithelial Hierarchy in the Mouse Mammary Gland Cold Spring Harb Symp Quant Biol, November 19, 2008; (2008) sqb.2008.73.020v2. [Abstract] [PDF]